Kai Ming Li

Cargill, Inc. engages in the provision of food, agricultural, financial, and industrial products and services. It specializes in food service, agriculture, meat and poultry, transportation, pharmaceutical ingredients, and beauty products. The company was founded by William Wallace Cargill in 1865 and is headquartered in Minneapolis, MN.

Sepp's Gourmet Foods Ltd. produces frozen waffles, pancakes and French toast for the retail and food service markets. It specializes in the organic, natural or functional food category. Its products can be classified into two categories: Prepared foods and Bakery. The prepared foods product category includes ready-to-eat items such as calzones, meat pies, sausage rolls, Cornish pasties, quiche and appetizers. The bakery product category includes items such as frozen waffles, pancakes, French toast and grilled cheese sandwiches. The company was founded on April 30, 1995 and is headquartered in Delta, Canada.

E. & J. Gallo Winery, Inc. engages in the production, distribution, and marketing of wines and spirits. Its portfolio includes Apothic, Carnivor, Chateau Souverain, Columbia Winery, Ecco Domani, and Edna Valley Vineyard. The company was founded by Ernest J. Gallo and Julio Gallo on September 22, 1933 and is headquartered in Modesto, CA.

Part of Nossack Food Group, Sepp's Fine Foods Ltd. produces and distributes specialty prepared foods. The company is based in Innisfail, Canada. Sepp's Fine Foods was acquired by Nossack Food Group from Sepp's Gourmet Foods Ltd. on March 04, 2008.

PROsnack Natural Foods, Inc. provides food services. Its products include energy, perk bars, product nutrition and gluten free. The company is headquartered in North Vancouver, Canada.

The Flowr Group, Inc. manufactures and distributes medical cannabis. The company was founded by Tom Flow, Steven A. Klein and David Miller. It is headquartered in Markham, Canada.

Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016.